Plinabulin as a novel small molecule clinical stage immuno-oncology agent for NSCLC.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of California San Diego, Moores Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2796942060
